Pharmaron Beijing Co., Ltd.
300759
Peringkat dalam Saham
#2354
Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a... Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotides, peptides, antibodies, antimicrobial agents, antibody-drug conjugates (ADCs), and cell and gene therapy products; small molecule CDMO services, such as API process development and production, material science and preformulation, formulation development, and analytical development. It also provides clinical research services; macromolecular and cell and gene therapy services comprising drug discovery, development and production services, cell and gene therapy laboratory services, and gene therapy drug development and production services. In addition, the company is involved in the provision of technology development, technology transfer, technical consultation, technical services, and technical training; import and export of goods and technologies. Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
Harga Saham
$5.58
Kapitalisasi Pasar
$8.24B
Perubahan (1 hari)
-3.77%
Perubahan (1 tahun)
28.36%
Negara
CN
Perdagangan Pharmaron Beijing Co., Ltd. (300759)
Kategori
Healthcare
Jumlah saham beredar untuk Pharmaron Beijing Co., Ltd. (300759)
Jumlah saham beredar per June 2026: 1.84B
Menurut laporan keuangan terbaru dan harga saham Pharmaron Beijing Co., Ltd., jumlah saham beredar saat ini adalah 1.84B. Pada akhir December 2024, perusahaan memiliki 1.77B saham beredar. Jumlah saham beredar biasanya dipengaruhi oleh pemecahan saham dan pembelian kembali saham.
Riwayat saham beredar untuk Pharmaron Beijing Co., Ltd. (300759) dari 2014 hingga 2026
Saham beredar pada akhir setiap tahun
| Tahun | Saham Beredar | Mengubah |
|---|---|---|
| 2026 (TTM) | 1.84B | 4.27% |
| 2025 | 1.76B | -0.44% |
| 2024 | 1.77B | -0.31% |
| 2023 | 1.78B | 0.12% |
| 2022 | 1.77B | 124.21% |
| 2021 | 790.81M | 0.07% |
| 2020 | 790.22M | 20.39% |
| 2019 | 656.41M | 7.15% |
| 2018 | 612.62M | -31.00% |
| 2017 | 887.91M | 17.11% |
| 2016 | 758.19M | 50.00% |
| 2015 | 505.46M | 0.00% |
| 2014 | 505.46M | 0.00% |
Saham beredar untuk perusahaan serupa atau pesaing
| Perusahaan | Saham Beredar | Perbedaan | Negara |
|---|---|---|---|
| 253.90M | -86.18% |
US
|
|
| 396.00M | -78.45% |
US
|
|
| 478.91M | -73.93% |
AU
|
|
| 0.00 | -100.00% |
BE
|
|
| 62.19M | -96.62% |
NL
|
